Your 101 guide to understanding HMPV
Since WHO platforms posted a few days ago a warning to those feeling symptoms of flu to stay at home and take precautions, the world seemed flooded by the trauma of a new COVID and the fear of it coming back after its onset five years ago.
On Monday, the Egyptian talk show Amr Adib hosted a panel of experts to address those fears in Egypt. The panel included Dr Hossam Abdel-Ghaffar, the spokesman for the Ministry of Health and Population; Dr Hossam Hosni, professor of chest diseases at Cairo University; and Dr Ashraf Omar, professor of hepatology at Cairo University.
The panel wrapped up the topic with several points, presenting a comprehensive guideline to understand the situation:
HMPV was first identified in 2001 and belongs to the Paramyxoviridae family. It is closely related to the respiratory syncytial virus (RSV) and can cause similar respiratory symptoms.
HMPV is a single-stranded RNA virus that primarily affects the respiratory tract. It spreads through respiratory secretions, such as coughing and sneezing, as well as through direct contact with infected individuals or contaminated surfaces.
The health ministry confirms that there are no documented HMPV cases in Egypt, noting that it was identified 24 years ago with a moderate spread rate.
Egypt actively monitors and responds to respiratory outbreaks like HMPV, implementing awareness campaigns, screenings, and medical care. Healthcare facilities are prepared to manage HMPV cases, providing treatment and support.
Common symptoms of HMPV infection include cough, fever, runny nose, sore throat, and difficulty breathing. In severe cases, it can lead to pneumonia or bronchiolitis, especially in young and older adults.
HMPV is highly contagious and can spread rapidly in crowded places, such as schools, daycare centres, and hospitals. Proper hand hygiene, covering coughs and sneezes, and avoiding close contact with sick individuals can help prevent transmission.
Infants, young children, older adults, and individuals with weakened immune systems are at higher risk of developing severe complications from HMPV infection. It is essential to take extra precautions to protect these vulnerable populations.
Short link:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Egypt Independent
10 hours ago
- Egypt Independent
FM, Palestinian PM visit Arish Hospital to check on the wounded from Gaza
Palestinian Prime Minister Mohamed Mostafa paid a visit on Monday, August 18, 2025, to Arish General Hospital, accompanied by Egyptian Minister of Foreign Affairs, Emigration and Expatriates Badr Abdelatty, to check on the condition of wounded Palestinians receiving treatment there. The officials reviewed the latest medical care provided to the injured who were transferred to Egypt as part of its ongoing efforts to receive thousands of wounded Palestinians and their companions for treatment. They also inspected the medical services and surgical interventions offered to civilians injured in the Israeli assault on the Gaza Strip. The Palestinian premier expressed deep appreciation for the comprehensive care provided to the wounded in Egyptian hospitals, praising Egypt's efforts to provide them with essential medical and surgical services.
Daily News Egypt
a day ago
- Daily News Egypt
Egypt, India's BDR Group in talks to establish biologics, cancer drug facility
Egypt's Minister of Health, Khaled Abdel Ghaffar, met Tuesday with Dharmesh Shah, Chairperson and Managing Director of India's BDR Group, to discuss plans for a joint pharmaceutical venture, including the establishment of a local facility for the production of biologics and cancer medications, according to a statement from the Ministry of Health. The meeting also included Gamal El-Leithy, CEO of Future Pharmaceuticals Industries (FPI) and head of Egypt's Chamber of Pharmaceutical Industry, as well as senior officials Hisham Stait, Head of the Unified Procurement Authority, and Ali El-Ghamrawy, Chairperson of the Egyptian Drug Authority. Minister Abdel Ghaffar emphasized Egypt's strategic goal of localizing pharmaceutical manufacturing and transferring advanced technology to enhance national drug security. He underscored the importance of partnering with global industry leaders to reduce reliance on imports and ensure access to affordable, high-quality medicines for Egyptian patients. Ministry spokesperson Hossam Abdel Ghaffar noted that the proposed facility aims to significantly lower the country's import bill for specialty drugs—particularly oncology treatments—which place considerable pressure on the national budget and foreign currency reserves. The project is expected to provide a stable, cost-effective supply of essential biologic therapies. The minister called for the swift implementation of the initiative, instructing relevant stakeholders to set a clear timeline and expedite the registration of products through the Egyptian Drug Authority. BDR Group representatives shared insights into the company's expertise in producing oncology drugs and biologics, highlighting successful international projects that have enhanced healthcare outcomes while reducing costs.
Daily News Egypt
2 days ago
- Daily News Egypt
Egypt's Supreme Organ Transplant Committee strengthens oversight, standards
Egypt's Supreme Committee for Organ Transplantation convened to assess the country's transplant program, reinforce regulatory oversight, and align practices with international medical standards, the Ministry of Health announced Monday. Health Ministry spokesperson Hossam Abdel Ghaffar stated that the meeting addressed several key areas, including the formation of specialized subcommittees, strategies to counter misinformation on social media, and the introduction of a new regulation limiting transplant approval validity to one year. Under this regulation, each transplant program must be affiliated with a single licensed medical facility. According to 2024 data, the committee issued 1,614 transplant approvals—1,194 for kidneys and 420 for livers. That year, 1,271 transplants were performed: 764 kidney and 234 liver transplants for Egyptian patients, and 188 kidney and 85 liver transplants for non-Egyptians. So far in 2025, 907 approvals have been issued (677 kidney, 230 liver). Egypt currently has 40 licensed transplant centers operating across public, university, private, police, and military hospitals. In 2024, the committee renewed licenses for 14 liver and 18 kidney centers and approved five new hospitals under licensing decision No. 124. Random inspections of transplant facilities will continue, with immediate corrective actions enforced in cases of non-compliance. The committee also reviewed mortality and morbidity data and discussed the governance of transplant procedures. One notable case involved a 62-year-old father successfully donating a kidney to his son after the procedure was cleared under Cabinet Decree No. 74 of 2023 and in accordance with Egypt's Organ Transplant Law No. 5 of 2010. Officials highlighted the urgent need for updated legislation and tighter oversight to safeguard the rights of both donors and recipients. Established in 2023 under Decree No. 4497 and chaired by Minister of Health Dr. Khaled Abdel Ghaffar, the Supreme Committee includes leading medical figures, such as world-renowned heart surgeon Sir Magdi Yacoub. It is supported by dedicated scientific, ethical, and licensing subcommittees to ensure that Egypt's transplant practices meet global medical and ethical benchmarks.
